Skip to main content

Ethical and Legal Aspects of Interventions in Addiction Treatment

  • Reference work entry
  • First Online:
Textbook of Addiction Treatment: International Perspectives

Abstract

The UN conventions present the international legal framework; they urge member states to provide treatment and rehabilitation but prohibit consumption and possession of scheduled drugs. This creates problems for providing treatment and harm reduction programs to patients who are not or not yet ready to stop illicit drug use. Other international documents, notably from the World Health Organization and the United Nations Office on Drugs and Crime, are strongly in favor of agonist substitution treatment and harm reduction measures. Within this framework, national legislation has much room for diverse preferences; the International Narcotic Control Board regularly comments the national practices, as well as the European Monitoring Centre for Drugs and Drug Addiction for the EU member states. An international trend gradually prefers therapeutic measures over criminal sanctions for drug users.

The international ethical framework is set by the universal declaration and European convention on human rights, striking a balance between individual rights and societal interests. Less ambiguous guidance comes from medical ethics claiming the full range of patient’s rights for addicted persons. The respective conduct codes for medical professions are regional or national and include procedures how to deal with ethical conflicts. Conflicting situations frequently occur, e.g., around the principles of autonomy or of confidentiality.

An essential ethical element of treatment is its effectiveness and avoidance of harm, asking for scientific evaluation of therapeutic approaches, services, and systems. The ethical acceptability of agonist substitution treatment and of harm reduction measures is based on rigorous evidence of their effectiveness. Other aspects concern the limits of social acceptability of addictive behavior and the limits of what can be attained for an individual patient by therapeutic interventions; avoidance of harm often is the more immediate objective than full recovery. In a public health perspective, effects at population level rather than at individual level are a priority, aiming at good coverage of treatment needs by good accessibility and affordability of services.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 339.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • AMA (2001) Principles of medical ethics. In: Code of medical ethics. American Medical Association, Chicago

    Google Scholar 

  • APA (2000) Diagnostic and statistical manual of mental disorders DSM IV TR. American Psychiatric Association, Arlington

    Google Scholar 

  • Arif A, Westermeyer J (1990) Methadone maintenance in the management of opioid dependence: an international review. Praeger, New York

    Google Scholar 

  • Arosemena G (2013) Conflicts of rights in international human rights: a meta-rule analysis. Glob Const 2:6–36

    Article  Google Scholar 

  • Bergmark A (2008) Specific and contextual treatment mechanisms. Nordic Stud Alcohol Drugs 25:277–285

    Google Scholar 

  • Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS (2007) Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess 11:1–171

    CAS  PubMed  Google Scholar 

  • Council of Europe (1950) Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine. Council of Europe, Rome

    Google Scholar 

  • Department of Health (2002) Models of care for substance misuse treatment. Promoting quality, efficiency and effectiveness in drug misuse treatment services. Department of Health, London

    Google Scholar 

  • Dole VP, Nyswander ME (1965) A medical treatment for diacetyl-morphine (heroin) addiction. JAMA 193:646–650

    Article  CAS  PubMed  Google Scholar 

  • Edlin BR, Keal KH, Lorwock J, Kral AH, Ciccarone DH, Moore LD, Lo B (2001) Is it justifiable to withhold treatment for hepatitis C from illicit drug users? New Engl J Med 345:211–215

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Edwards G, Arif A (1980) Dug problems in a socio-cultural context. A basis for policy and programme planning. Public health papers no. 73. World Health Organisation, Geneva

    Google Scholar 

  • Ekendahl M (2007) Will and skill – an exploratory study of substance abuser’s attitudes towards life-style changes. Eur Addict Res 13:148–155

    Article  PubMed  Google Scholar 

  • Elliot HM (1920) Memoirs of Jahangir. Islamic Book Service, Lahore

    Google Scholar 

  • Emcdda (2009) Special issue 2009. Drug offences; sentencing and other outcomes. European Monitoring Centre on Drugs and Drug Addiction, Lisbon. www.emcdda.europa.eu/publications/selected-issues/sentencing-statistics. Accessed 14 Feb 2013

  • EMCDDA (2012) www.emcdda.europa.eu/publications/country-overviews

  • EU (2005) EU drug action plan. Brussels, Amtsblatt der Europäischen Union 2005/C168/01

    Google Scholar 

  • Farrell M, Ward J, Mattick R, Hall W, Stimson GV, des Jarlais D, Gossop M, Strang J (2004) Methadone maintenance treatment in opiate dependence: a review. Brit Med J 309:997–1001

    Article  Google Scholar 

  • Fireman M, Rabkin JM (2001) Outcome of liver transplantation in patients with alcohol and other. Chemical dependence. Psychosomatics 42:172–173

    Google Scholar 

  • Freud S (1884). Ăœber Coca. Centralblatt fĂ¼r die gesamte Therapie 2:289–314

    Google Scholar 

  • General Medical Council (2006) Good medical practice. Regulating doctors. Ensuring good medical practice. General Medical Council, London

    Google Scholar 

  • Gerdner A (1998) Patient and programme factors with impact on outcome in Swedish compulsory care of addicts: a systematic review. Lund University, Sweden

    Google Scholar 

  • Gerstein DR, Datta AR, Ingels JS, Johnson RA, Rasinski KA, Schildhaus S, Talley K (1997) NTIES. The National Treatment Improvement Evaluation Study. Final report. National Opinion Research Center, Chicago

    Google Scholar 

  • Gossop M (2006) Treating drug misuse problems: evidence of effectiveness. National Treatment Agency for Substance Misuse, London

    Google Scholar 

  • Gossop M, Marsden J, Stewart D, Kidd T (2003) The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction 98:291–303

    Article  PubMed  Google Scholar 

  • Health Canada (2008) Literature review – methadone maintenance treatment. Public Works and Government Services Canada, Ottawa

    Google Scholar 

  • Hubbard RL, Craddock SG, Anderson J (2003) Overview of 5-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 25:126–134

    Article  Google Scholar 

  • INCB (2011) Report of the International Narcotic Control Board for 2011. http://www.incb.org/incb/en/publications/annual-reports/annual-report-2011.html

  • Kaya CY, Tugai Y, Filar JA, Agrawal MR, Ali RL, Gowing LR, Cooke R (2004) Heroin users in Australia: population trends. Drug Alcohol Rev 23:107–116

    Article  PubMed  Google Scholar 

  • Klingemann H, Sobell LC (2007) Promoting self-change from addictive behaviors. Practical implications for policy, prevention and treatment. Springer, New York

    Google Scholar 

  • Kramer JC (1977) Heroin in the treatment of morphine addiction. J Psychedelic Drugs 197:193–197

    Article  Google Scholar 

  • Leshner A (1997) Addiction is a brain disease, and it matters. Science 278:45–47

    Article  CAS  PubMed  Google Scholar 

  • Marsh KL, Joe GW, Simpson DD, Lehmann WEK (1990) Treatment history. In: Simpson DD, Sells SB (eds) Opioid addiction and treatment: a 12-year follow-up. Krieger, Malabar, pp 137–156

    Google Scholar 

  • McLellan AT, Grissom GR, Zanis D, Randall M, Brill P, O’Brien CP (1997) Problem-service ‘matching’ in addiction treatment. A prospective study in 4 programs. Arch Gen Psychiat 54:730–735

    Article  CAS  PubMed  Google Scholar 

  • Metzger DS, Woody GE, McLellan AT (1993) Human Immunodeficiency Virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 6:1049–1056

    CAS  PubMed  Google Scholar 

  • MHR (1995) Order from the Ministry of Health of Russia dated 14 August 1995 #239, titled About additional measures on control of narcotic drugs, dangerous substances and poisons

    Google Scholar 

  • Miller N, Flaherty JA (2000) Effectiveness of coerced addiction treatment (alternative consequences) a review of the clinical research. J Subst Abuse Treat 18:9–16

    Article  CAS  PubMed  Google Scholar 

  • Moyer A, Finney JW, Swearingen CE, Vergun P (2002) Brief interventions for alcohol problems: a meta-analytic review of controlled investigations into treatment-seeking and non-treatment-seeking populations. Addiction 97:279–292

    Article  PubMed  Google Scholar 

  • NIDA (2012) Principles of drug addiction treatment. A research-based guide. National Institute of Drug Abuse, Bethesda

    Google Scholar 

  • Rhodes T, Hedrich D (eds) (2010) Harm reduction: evidence, impact and challenges. EMCDDA Monograph. European Monitoring Centre for Drugs and Drug Addiction, Lisbon

    Google Scholar 

  • Robins LN (1993) Vietnam veterans rapid recovery from heroin addiction – a fluke or normal expectation. Addiction 88:1041–1054

    Article  CAS  PubMed  Google Scholar 

  • Rust A (2000) Ethische Aspekte. In: Uchtenhagen A, Zieglgänsberger W (eds) Suchtmedizin. Konzepte, Strategien und therapeutisches Management. Urban & Fischer, MĂ¼nchen, pp 573–584

    Google Scholar 

  • Schumacher JE, Milby JB, Wallace D, Meehan DC, Kertesz S, Vuchinich R, Dunning J, Usdan S (2007) Meta-analysis of day treatment and contingency-management dismantling research: Birmingham homeless cocaine studies (1990–2006). J Consult Clin Psychol 75:823–828

    Article  PubMed  Google Scholar 

  • Stallwitz A, Stoever H (2007) The impact of substitution treatment in prisons – a literature review. Int J Drug Policy 18:464–474

    Article  PubMed  Google Scholar 

  • Stevens A, Hallam C, Trace M (2006) Treatment for dependent drug use. A guide for policymakers. Beckley Foundation, London

    Google Scholar 

  • Tännsjö T (1999) Coercive care. The ethics of choice in health and medicine. Routledge, London

    Google Scholar 

  • Uchtenhagen A (2003). Substitution management in opioid dependence. J Neurol Transmission, suppl 66: Fleischhacker WW, Brooks DJ (eds) Addictions, mechanisms, phenomenology and treatment, p 33–60

    Google Scholar 

  • Uchtenhagen A (2010a) Treatment of substance dependence: ethical aspects. In: Helmchen H, Sartorius N (eds) Ethics in psychiatry – European contributions. Springer, Amsterdam, pp 381–400

    Chapter  Google Scholar 

  • Uchtenhagen A (2010b) Ethical perspectives in caring for people living with addictions: the European experience. Int Rev Psychiatry 22:274–280

    Article  PubMed  Google Scholar 

  • Uchtenhagen A, GuggenbĂ¼hl L (2000) Adequacy in Drug Abuse Treatment and Care in Europe (ADAT). Commissioned by World Health Organisation, Regional Office for Europe. Research Institute for Public Health and Addiction, Zurich

    Google Scholar 

  • Uchtenhagen A, Ladjevic T, Rehm J (2005) Guidelines for psychosocially assisted pharmacological treatment of persons dependent on opioids. Working paper for World Health Organisation. Research Institute for Public Health and Addiction, Zurich

    Google Scholar 

  • UN (1948) Universal declaration of human rights. United Nations, New York

    Google Scholar 

  • UN (1961) Single convention on narcotic drugs. United Nations, New York

    Google Scholar 

  • UN (1971) Convention on psychotropic substances. United Nations, New York

    Google Scholar 

  • UN (1988) United Nations convention against illicit traffic in narcotic drugs and psychotropic substances. United Nations, New York

    Google Scholar 

  • UNODC/WHO/UNAIDS (2009) Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. United Nations Office on Drugs and Crime, Vienna

    Google Scholar 

  • Ward J, Mattick R, Hall W (1998) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam

    Google Scholar 

  • Weisner C (1990) Coercion in alcohol treatment. In: Institute of Medicine (ed) Broadening the base for the treatment of alcohol problems. The National Academic Press, Washington, DC, pp 579–610

    Google Scholar 

  • Westermeyer J (1982) Poppies, pipes and people: opium and its use in Laos. University of California Press, Berkeley

    Google Scholar 

  • Westermeyer J (2006) The switch from opium to heroin smoking. Addiction 92:686–687

    Article  Google Scholar 

  • WHO (2004a) Proposal for the inclusion of Methadone in the WHO model list of essential medicines. World Health Organisation, Geneva

    Google Scholar 

  • WHO (2004b) Proposal for the inclusion of buprenorphine in the WHO model list of essential medicines. World Health Organisation, Geneva

    Google Scholar 

  • WHO (2008) Guidelines for psychosocially assisted pharmacological treatments of opioid dependence. World Health Organisation, Geneva

    Google Scholar 

  • WHO (2009) Assessment of compulsory treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: an application of selected human rights principles. World Health Organisation, Manila

    Google Scholar 

  • WHO (2010) International classification of diseases (10th ed) Version for 2010. World Health Organisation, WHO/UNODC (2008). Principles of drug dependence treatment. A discussion paper. World Health Organisation, Geneva

    Google Scholar 

  • Wild DC, Cunningham JA, Ryan RM (2006) Social pressure, coercion, and client engagement at treatment entry: a self-determination theory perspective. Addict Behav 31:1858–1872

    Article  PubMed  Google Scholar 

  • Zinberg NE (1984) Drug, set and setting. Yale University Press, New Haven

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ambros Uchtenhagen .

Editor information

Editors and Affiliations

Additional information

Note: Some of the material is based on earlier work of the author about ethical aspects of treatment and care in addiction (Uchtenhagen & GuggenbĂ¼hl 2000; Uchtenhagen et al. 2005; Uchtenhagen 2010a, b).

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this entry

Cite this entry

Uchtenhagen, A. (2015). Ethical and Legal Aspects of Interventions in Addiction Treatment. In: el-Guebaly, N., CarrĂ , G., Galanter, M. (eds) Textbook of Addiction Treatment: International Perspectives. Springer, Milano. https://doi.org/10.1007/978-88-470-5322-9_65

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5322-9_65

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5321-2

  • Online ISBN: 978-88-470-5322-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics